Lumentum holder plans sale of 4,849 shares

Lumentum Holdings has an investor planning to sell 4,849 shares of its common stock through UBS Financial Services on Nasdaq, with an approximate sale date of 02/06/2026 and an aggregate market value of 2,596,536.31.

Rhea-AI Filing Summary

Lumentum Holdings has an investor planning to sell 4,849 shares of its common stock through UBS Financial Services on Nasdaq, with an approximate sale date of 02/06/2026 and an aggregate market value of 2,596,536.31.

The notice states that 71,400,000 common shares were outstanding and shows these shares were acquired via restricted stock unit (RSU) vestings on 11/18/2021 and 11/17/2024, totaling 1,600 and 3,249 shares respectively, each paid in cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Lumentum (LITE) shares are proposed to be sold under this Form 144?

The notice covers a proposed sale of 4,849 Lumentum common shares. These shares are listed with an aggregate market value of 2,596,536.31 and are planned to be sold through UBS Financial Services on Nasdaq on or around 02/06/2026.

What is the aggregate market value of the Lumentum (LITE) shares to be sold?

The 4,849 Lumentum common shares have an aggregate market value of 2,596,536.31. This figure reflects the total market value associated with the planned sale, as disclosed alongside the share count and other transactional details in the notice.

How were the Lumentum (LITE) shares in this Form 144 acquired?

The shares were acquired through restricted stock unit (RSU) vestings from Lumentum Holdings. One RSU vesting on 11/18/2021 delivered 1,600 shares, and another on 11/17/2024 delivered 3,249 shares, with payment for both vestings made in cash on the respective vesting dates.

When is the approximate sale date for the Lumentum (LITE) shares in this notice?

The approximate sale date disclosed is 02/06/2026. This date applies to the planned sale of 4,849 common shares through UBS Financial Services on Nasdaq, as indicated in the securities information section of the notice.

How many Lumentum (LITE) shares were outstanding according to this Form 144?

The notice states that 71,400,000 Lumentum common shares were outstanding. This figure provides context for the issuer’s total share base at the time referenced, alongside the smaller 4,849-share amount covered by the proposed sale.

Which broker and exchange are involved in this Lumentum (LITE) share sale?

The proposed sale is to be executed through UBS Financial Services Inc., located at 1000 Harbor Blvd, Weehawken, NJ. The shares are expected to be sold on the Nasdaq exchange, as specified in the securities information section of the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/06/2026 - 12:32 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001232019
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Lumentum Holdings Inc
SEC File Number	001-36861
Address of Issuer	1001 Ridder Park Dr San Jose CALIFORNIA 95131
Phone	408-546-5483
Name of Person for Whose Account the Securities are To Be Sold	Penelope Herscher
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	4849	2596536.31	71400000	02/06/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/18/2021	RSU vesting	Lumentum Holdings			1600	11/18/2021	cash
Common	11/17/2024	RSU vesting	Lumentum Holdings			3249	11/17/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/JOSEPH CASSIDY, for UBS Financial Services Inc, as attorney-in-fact for Penelope Herscher
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)